Applied DNA Announces Pricing of $2.75 Million Offering of Common Stock and Warrants – Global Banking And Finance Review
Applied DNA Announces Pricing of $2.75 Million Offering of Common Stock and Warrants Global Banking And Finance Review Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the “Company”), a leader in large-scale PCR-based DNA manufacturing, announced today the … … Continue reading →